Quanterix Q3 2024 Earnings Report
Key Takeaways
Quanterix announced preliminary financial results for Q3 2024, achieving its sixth consecutive quarter of double-digit growth with a revenue of $35.7 million, a 13% increase compared to the prior year, and reaffirmed its full year 2024 revenue guidance of $134 million to $138 million. The company also disclosed the need to restate certain prior period financial statements.
Revenue of $35.7 million, a 13% increase compared to the corresponding prior year period.
GAAP gross margin of 58.9% and Non-GAAP gross margin of 53.4%.
Net cash usage in the quarter was $3.3 million.
Launched LucentAD Complete, a multi-marker test for Alzheimer’s Disease (AD) detection.
Quanterix
Quanterix
Forward Guidance
The Company reaffirms its 2024 revenue guidance range of $134 million to $138 million. The Company continues to expect GAAP gross margin percentage to be in the range of 57%-61%, and non-GAAP gross margin percentage to be in the range of 51%-55%. The Company continues to anticipate 2024 cash usage to be approximately $30 million.